Mr. Salil Shetty designation is changed from Non Executive Director to Executive Director & CEO of the Company w.e.f. 1 April, 2026 subject to approval of the Shareholders of the Company ....
Awaiting price reaction for this filing.
Bijoy Hans Limited held a board meeting on March 17, 2026, and approved a wide range of proposals that will go to shareholders via a postal ballot. The company plans to rename itself 'Arvaya Healthcare Limited', signaling a likely strategic shift toward the healthcare sector. The board approved raising the authorised share capital from Rs. 60 crore to Rs. 200 crore and increasing borrowing and investment limits each to Rs. 200 crore. Leadership changes include elevating Mr. Salil Shetty from Non-Executive Director to Executive Director and CEO effective April 1, 2026, along with revisions in remuneration for the Managing Director and CFO. The board also approved a new set of Articles of Association and issued a non-binding Letter of Intent to GTT Data Solutions for a technology platform worth up to Rs. 5 crore.
The proposed rebrand to a healthcare-focused name, combined with a more than 3x jump in authorised capital and large new borrowing and investment powers, suggests the company is preparing for a major business pivot, expansion, or acquisition. These are shareholder-friendly signals on growth intent, but execution risk is high since all key items still need shareholder approval through the postal ballot.